Breaking News Bar

Business News and Information

Flagship launches 2nd microbiome-based biotech

New startup Kintai Therapeutics emerged from stealth mode Tuesday with plans to bring multiple drugs to the clinic and "recruit aggressively" for as many as 100 employees by the end of the year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear